Don’t miss the latest developments in business and finance.

Top headlines: Sebi chief speaks on IPO valuations; Omicron spreads

Slice, a credit-card startup targeting young consumers, raised $220 million to become India's latest unicorn. More on that story in our top headlines.

omicron
Microscopic view of covid-19 omicron variant or B.1.1.529. 3D rendering
BS Web team New Delhi
2 min read Last Updated : Nov 29 2021 | 7:19 AM IST
As the Omicron coronavirus variant spread around the world on Sunday, experts said developing antivirals is the way forward to combat the disease. More on that story in our top headlines.

New Covid-19 variant: Antivirals hold the key as mutations surface 

With Omicron appearing on the scene as the new variant of concern, experts say developing antivirals is the way forward to combat Covid in the long run. 

If the ever-mutating virus keeps evading the vaccine-induced immunity, one can think of next-generation Covid vaccines, but it is antivirals that hold the key to combating the virus, say scientists. Read more 

Sebi won't interfere with IPO valuations, says chairman

Ajay Tyagi’s four-year-and-nine-month stint as chairman of market watchdog Securities and Exchange Board of India (Sebi) has been largely successful. In an exclusive interview with Samie Modak, Tyagi shares his views on various issues concerning the markets.  Read more

 
Start-up pay cheques, ESOPs create new breed of angel investors 

The profile of the typical angel investor - someone who bets on early stage start-ups - is changing. It was always an HNI or founder or CXO of a start-up who had made money on big bang exits. Read more


Fintech start-up slice turns India's 41st unicorn in 2021

Fintech start-up slice has raised $220 million in a Series B round that values the company at over $1 billion, making it the latest entrant to India’s coveted unicorn club. Read more


Why Rakesh Jhunjhunwala's Akasa Air could prove the sceptics wrong 

At the recently concluded Dubai airshow, Akasa, Rakesh Radheyshyam Jhunjhunwala’s new airline, signed a $9 billion deal with American aircraft maker Boeing to buy its 737 MAX planes and a $4 billion one for engines with CFM, a joint venture between GE of the US and Safran of France.  Read more


Topics :CoronavirusRakesh JhunjhunwalaAkasa AirIPOSEBICoronavirus Vaccine

Next Story